1205 related articles for article (PubMed ID: 16949718)
21. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
22. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum.
Musella A; De Chiara V; Rossi S; Cavasinni F; Castelli M; Cantarella C; Mataluni G; Bernardi G; Centonze D
Neuroscience; 2010 May; 167(3):864-71. PubMed ID: 20219639
[TBL] [Abstract][Full Text] [Related]
23. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
24. Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle.
Hutchins-Wiese HL; Li Y; Hannon K; Watkins BA
J Nutr Biochem; 2012 Aug; 23(8):986-93. PubMed ID: 22051448
[TBL] [Abstract][Full Text] [Related]
25. Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system.
Amadio D; Fezza F; Catanzaro G; Incani O; van Zadelhoff G; Finazzi Agrò A; Maccarrone M
Biochimie; 2010 Apr; 92(4):378-87. PubMed ID: 20096328
[TBL] [Abstract][Full Text] [Related]
26. Critical enzymes involved in endocannabinoid metabolism.
Basavarajappa BS
Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
[TBL] [Abstract][Full Text] [Related]
27. Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation.
Gervasi MG; Osycka-Salut C; Caballero J; Vazquez-Levin M; Pereyra E; Billi S; Franchi A; Perez-Martinez S
PLoS One; 2011 Feb; 6(2):e16993. PubMed ID: 21347292
[TBL] [Abstract][Full Text] [Related]
28. Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor.
Bariani MV; Domínguez Rubio AP; Cella M; Burdet J; Franchi AM; Aisemberg J
Reproduction; 2015 Dec; 150(6):463-72. PubMed ID: 26347521
[TBL] [Abstract][Full Text] [Related]
29. Localization of an endocannabinoid system in the hypophysial pars tuberalis and pars distalis of man.
Yasuo S; Unfried C; Kettner M; Geisslinger G; Korf HW
Cell Tissue Res; 2010 Nov; 342(2):273-81. PubMed ID: 20957495
[TBL] [Abstract][Full Text] [Related]
30. The endocannabinoid system in neurodegeneration.
Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
[TBL] [Abstract][Full Text] [Related]
31. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF
Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
[TBL] [Abstract][Full Text] [Related]
32. A putative 'pre-nervous' endocannabinoid system in early echinoderm development.
Buznikov GA; Nikitina LA; Bezuglov VV; Francisco ME; Boysen G; Obispo-Peak IN; Peterson RE; Weiss ER; Schuel H; Temple BR; Morrow AL; Lauder JM
Dev Neurosci; 2010 Mar; 32(1):1-18. PubMed ID: 19907129
[TBL] [Abstract][Full Text] [Related]
33. Endocannabinoid metabolic pathways and enzymes.
Ligresti A; Cascio MG; Di Marzo V
Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
[TBL] [Abstract][Full Text] [Related]
34. The endocannabinoid system is modulated in response to spinal cord injury in rats.
Garcia-Ovejero D; Arevalo-Martin A; Petrosino S; Docagne F; Hagen C; Bisogno T; Watanabe M; Guaza C; Di Marzo V; Molina-Holgado E
Neurobiol Dis; 2009 Jan; 33(1):57-71. PubMed ID: 18930143
[TBL] [Abstract][Full Text] [Related]
35. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
Laricchiuta D; Centonze D; Petrosini L
Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
[TBL] [Abstract][Full Text] [Related]
36. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson JL; Bilbrey JA; Felix JS; Makriyannis A; McMahon LR
Pharmacol Biochem Behav; 2021 Jul; 206():173192. PubMed ID: 33932409
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of endocannabinoids.
Biernacki M; Skrzydlewska E
Postepy Hig Med Dosw (Online); 2016 Aug; 70(0):830-43. PubMed ID: 27516570
[TBL] [Abstract][Full Text] [Related]
38. Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells.
Maccarrone M; Fiori A; Bari M; Granata F; Gasperi V; De Stefano ME; Finazzi-Agrò A; Strom R
Thromb Haemost; 2006 Jan; 95(1):117-27. PubMed ID: 16543970
[TBL] [Abstract][Full Text] [Related]
39. Identification of endocannabinoids and related compounds in human fat cells.
Gonthier MP; Hoareau L; Festy F; Matias I; Valenti M; Bès-Houtmann S; Rouch C; Robert-Da Silva C; Chesne S; Lefebvre d'Hellencourt C; Césari M; Di Marzo V; Roche R
Obesity (Silver Spring); 2007 Apr; 15(4):837-45. PubMed ID: 17426318
[TBL] [Abstract][Full Text] [Related]
40. FAAH and anandamide: is 2-AG really the odd one out?
Di Marzo V; Maccarrone M
Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
